These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4072249)

  • 21. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism and disposition of the dopaminergic agonist 5-hydroxy-6-methyl-2-di-n-propylaminotetralin in the rat.
    Koble DL; Koons JC; Fischer LJ
    Drug Metab Dispos; 1985; 13(3):305-11. PubMed ID: 2861988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereochemistry of the major rat liver microsomal metabolites of the carcinogen 7-methylbenz[c]acridine.
    Duke CC; Hambley TW; Holder GM; Navascues CO; Roberts-Thomson S; Ye YR
    Chem Res Toxicol; 1991; 4(5):546-55. PubMed ID: 1793804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of microsomal enzyme inducers on the urinary excretion pattern of mutagenic metabolites of the carcinogen 2,4-toluenediamine.
    Reddy TV; Ramanathan R; Benjamin T; Grantham PH; Weisburger EK
    J Natl Cancer Inst; 1986 Feb; 76(2):291-7. PubMed ID: 3456067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism of 1-propyl-1-nitrosourea (PNU) in rats.
    Tanaka A; Watanabe M
    IARC Sci Publ; 1982; (41):483-91. PubMed ID: 7141555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of ractopamine hydrochloride metabolites excreted in rat bile.
    Smith DJ; Giddings JM; Feil VJ; Paulson GD
    Xenobiotica; 1995 May; 25(5):511-20. PubMed ID: 7571724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of metabolism in the biliary excretion of methadone metabolites.
    Roerig DL; Hasegawa AT; Wang RI
    J Pharmacol Exp Ther; 1976 Oct; 199(1):93-102. PubMed ID: 978487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enterohepatic circulation in rat and dog of 14C-0-[3-(4-less than 2-methoxyphenyl greater than-1-piperazinyl)-2-hydroxypropyl]-3-methoxy-benzaldoxim dihydrochloride and it's demethylated metabolite.
    Paul H; Illing A; House ES
    Eur J Drug Metab Pharmacokinet; 1981; 6(4):303-12. PubMed ID: 7333331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of methadone dose on the biliary excretion of methadone metabolites in the rat.
    Roerig DL; Hasegawa AT; Wang RI
    Drug Metab Dispos; 1976; 4(4):407-12. PubMed ID: 8297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The distribution and excretion of 14C- and 3H-labelled 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in the rat.
    Dean HG; Donovan B; Rylett P
    Arzneimittelforschung; 1976; 26(8):1574-81. PubMed ID: 1036955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of desipramine treatment on the biliary, fecal and urinary excretion of methadone in the rat.
    Liu SJ; Chen KZ; Wang RI
    J Pharmacol Exp Ther; 1976 Aug; 198(2):308-17. PubMed ID: 948028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism, excretion, and pharmacokinetics of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid, an EP2 receptor-selective prostaglandin E2 agonist, in male and female Sprague-Dawley rats.
    Johnson KA; Prakash C
    Drug Metab Dispos; 2005 Aug; 33(8):1191-201. PubMed ID: 15886349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enterohepatic circulation of l-alpha-acetylmethadol in the rat.
    Roerig DL; Hasegawa AT; Wang RI
    J Pharmacol Exp Ther; 1980 May; 213(2):284-8. PubMed ID: 7365687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolism and excretion of a new 5-lipoxygenase inhibitor in rats, guinea-pigs, beagles and rhesus monkeys.
    Yoshimura T; Tanaka S; Sakurai H; Nagai Y; Yamada K; Katayama S; Abe S; Yamatsu I
    Xenobiotica; 1991 May; 21(5):627-34. PubMed ID: 1949895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism and excretion of 14C-tiropramide after single intravenous or peroral administration to the rat.
    Setnikar I; Makovec F; Chistè R; Giachetti C; Zanolo G
    Arzneimittelforschung; 1989 Mar; 39(3):328-34. PubMed ID: 2757659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism of 6-methylbenz[a]anthracene by rat liver microsomes and mutagenicity of metabolites.
    Mushtaq M; Fu PP; Miller DW; Yang SK
    Cancer Res; 1985 Sep; 45(9):4006-14. PubMed ID: 3896475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of trans-4-acetylaminostilbene metabolism in the rat by methylcholanthrene and phenobarbital and its relevance for acute toxicity.
    Pfeifer A; Neumann HG
    Drug Metab Dispos; 1988; 16(2):276-84. PubMed ID: 2898347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
    Prakash C; Kamel A; Anderson W; Howard H
    Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disposition in rats and mice of chloropractolol, a new beta-blocking agent.
    Godeneche D; Pilichowski JF; Meyniel G
    Xenobiotica; 1980 Sep; 10(9):725-33. PubMed ID: 6108651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.